Publicacións en colaboración con investigadores/as de Swiss Federal Institute of Technology in Zurich (2)

2016

  1. Independent candidate serum protein biomarkers of response to adalimumab and to infliximab in rheumatoid arthritis: An exploratory study

    PLoS ONE, Vol. 11, Núm. 4

2012

  1. Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis

    Journal of Proteomics, Vol. 77, pp. 372-382